Ranibizumab

Item number	Size	Delivery time	Price
TGM-T9928-1mg	1 mg	7 - 10 business days*	321.00€
TGM-T9928-5mg	5 mg	7 - 10 business days*	846.00€
TGM-T9928-10mg	10 mg	7 - 10 business days*	1,353.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Ranibizumab is a humanized monoclonal antibody fragment designed to target and... more

Close menu

Product information "Ranibizumab"

Description: Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD). Target: VEGFR. References: Klettner A, et al.Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.Invest Ophthalmol Vis Sci. 2008 Oct,49(10):4523-7.

Supplier:	TargetMol
Supplier-Nr:	T9928

Properties

Conjugate:	No
MW:	48 kD

Database Information

KEGG ID :	K05448 \| Matching products
UniProt ID :	P15692 \| Matching products
Gene ID :	GeneID 7422 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Ranibizumab"

Write a review